Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Liver Resection | Research

Liver resection for hepatocellular carcinoma in oldest old patients

Authors: Feng-Hsu Wu, Ching-Hui Shen, Shao-Ciao Luo, Jen-I Hwang, Wen-Shan Chao, Hong-Zen Yeh, Yee-Gee Jan, Yun Yen, Shao-Bin Cheng, Cheng-Chung Wu, Yi-Ling Lin, Fang-Ku P’eng

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Background

For hepatocellular carcinoma (HCC), liver resection is a classical curative modality, despite its technical complexity. The incidence of HCC in the oldest old people (aged ≥ 85 years) is rising along with the global increase in life expectancy. Currently, no report has addressed liver resection for HCC in this aged population.

Patients and methods

We conducted a retrospective review of 1889 patients receiving curative liver resection for newly diagnosed HCC from 1992 to 2016. At the time of operation, 1858 of them were aged < 85 years (group A), and 31 were aged ≥ 85 years (group B). Another 18 oldest old patients, whose HCC was considered resectable but were not operated on due to the patient’s refusal, served as the control group (group C). The clinicopathological characteristics and early and long-term outcomes were compared between groups A and B. All associated co-morbidities of the patients were well-treated before liver resection. The overall survival (OS) rates were also compared between groups B and C.

Result

Group B had a significantly higher incidence of associated co-morbidities and hepatitis C infection. Postoperative complication rates and 90-day mortality rates after liver resection did not differ between groups A and B (p = 0.834 and p = 1.000, respectively), though group B had a longer postoperative stay (p = 0.001). In groups A and B, the 5-year disease-free survival rates were 29.7% and 22.6% (p = 0.163), respectively, and their overall survival rates were 43.5% and 35.5% (p = 0.086). The overall survival rate of group B was significantly different from group C (35.5% vs. 0%, p = 0.001).

Conclusion

Despite a longer postoperative recovery period, liver resection for HCC in the oldest old patients may be justified if co-morbidities are well controlled.
Literature
1.
go back to reference Wu CC. Progress of liver resection for hepatocellular carcinoma in Taiwan. Jpn J ClinOncol. 2017;47(5):375–80.CrossRef Wu CC. Progress of liver resection for hepatocellular carcinoma in Taiwan. Jpn J ClinOncol. 2017;47(5):375–80.CrossRef
2.
go back to reference Cheng AL, Amarapurkar D, Chao Y, et al. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: consensus recommendations and review by an International Expert Panel. Liver Int. 2014;34(2):174–83.CrossRef Cheng AL, Amarapurkar D, Chao Y, et al. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: consensus recommendations and review by an International Expert Panel. Liver Int. 2014;34(2):174–83.CrossRef
3.
go back to reference Toro A, Pulvirenti E, Palermo F, Di Carlo I. Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. SurgOncol. 2012;21(1):e23–30. Toro A, Pulvirenti E, Palermo F, Di Carlo I. Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. SurgOncol. 2012;21(1):e23–30.
4.
go back to reference Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10(1):25–34.CrossRef Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10(1):25–34.CrossRef
5.
go back to reference Yasunaga H, Horiguchi H, Matsuda S, et al. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese Diagnosis Procedure Combination database. Hepatol Res. 2012;42(11):1073–80.CrossRef Yasunaga H, Horiguchi H, Matsuda S, et al. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese Diagnosis Procedure Combination database. Hepatol Res. 2012;42(11):1073–80.CrossRef
6.
go back to reference Kowal P, Dowd JE. Definition of an older person. Proposed working definition of an older person in Africa for the MDS Project. World Health Organization, Geneva, doi. 2001;10 (2.1):5188.9286. Kowal P, Dowd JE. Definition of an older person. Proposed working definition of an older person in Africa for the MDS Project. World Health Organization, Geneva, doi. 2001;10 (2.1):5188.9286.
8.
go back to reference Wu CC, Chen JT, Ho WL, et al. Liver resection for hepatocellular carcinoma in octogenarians. Surgery. 1999;125(3):332–8.CrossRef Wu CC, Chen JT, Ho WL, et al. Liver resection for hepatocellular carcinoma in octogenarians. Surgery. 1999;125(3):332–8.CrossRef
9.
go back to reference Nozawa A, Kubo S, Takemura S, et al. Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century. Surg Today. 2015;45(7):851–7.CrossRef Nozawa A, Kubo S, Takemura S, et al. Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century. Surg Today. 2015;45(7):851–7.CrossRef
10.
go back to reference Inoue Y, Tanaka R, Fujii K, et al. Surgical outcome and hepatic regeneration after hepatic resection for hepatocellular carcinoma in elderly patients. Dig Surg. 2018. p. 1–13. [Epub ahead of print] Inoue Y, Tanaka R, Fujii K, et al. Surgical outcome and hepatic regeneration after hepatic resection for hepatocellular carcinoma in elderly patients. Dig Surg. 2018. p. 1–13. [Epub ahead of print]
11.
go back to reference Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg. 1990;211(2):141–5.CrossRef Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg. 1990;211(2):141–5.CrossRef
12.
go back to reference Takenaka K, Shimada M, Higashi H, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg. 1994;129(8):846–50.CrossRef Takenaka K, Shimada M, Higashi H, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg. 1994;129(8):846–50.CrossRef
13.
go back to reference Shirabe K, Kajiyama K, Harimoto N, et al. Early outcome following hepatic resection in patients older than 80 years of age. World J Surg. 2009;33(9):1927–32.CrossRef Shirabe K, Kajiyama K, Harimoto N, et al. Early outcome following hepatic resection in patients older than 80 years of age. World J Surg. 2009;33(9):1927–32.CrossRef
14.
go back to reference Riffat F, Chu F, Morris DL. Liver resection in octogenarians. HPB (Oxford). 2006;8(3):206–10.CrossRef Riffat F, Chu F, Morris DL. Liver resection in octogenarians. HPB (Oxford). 2006;8(3):206–10.CrossRef
16.
go back to reference Wu CC, Hseih S, Ho WM, Tang JS, Liu TJ, P'Eng FK. Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: using cardiopulmonary bypass and deep hypothermic circulatory arrest. J SurgOncol. 2000;74(3):227–31. Wu CC, Hseih S, Ho WM, Tang JS, Liu TJ, P'Eng FK. Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: using cardiopulmonary bypass and deep hypothermic circulatory arrest. J SurgOncol. 2000;74(3):227–31.
17.
go back to reference Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRef Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRef
18.
go back to reference Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. SeminSurgOncol. 1993;9(4):298–304. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. SeminSurgOncol. 1993;9(4):298–304.
19.
go back to reference Cheng SB, Wu CC, Shu KH, et al. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure. J SurgOncol. 2001;78(4):241–6 discussion 246-247. Cheng SB, Wu CC, Shu KH, et al. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure. J SurgOncol. 2001;78(4):241–6 discussion 246-247.
20.
go back to reference Wu CC, Cheng SB, Ho WM, et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery. 2004;136(3):660–8.CrossRef Wu CC, Cheng SB, Ho WM, et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery. 2004;136(3):660–8.CrossRef
21.
go back to reference Liu HT, Cheng SB, Wu CC, Yeh HZ, Chang CS, Wang J. Impact of severe oesophagogastricvarices on liver resection for hepatocellular carcinoma in cirrhotic patients. World J Surg. 2015;39(2):461–8.CrossRef Liu HT, Cheng SB, Wu CC, Yeh HZ, Chang CS, Wang J. Impact of severe oesophagogastricvarices on liver resection for hepatocellular carcinoma in cirrhotic patients. World J Surg. 2015;39(2):461–8.CrossRef
22.
go back to reference Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431–5.CrossRef Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431–5.CrossRef
23.
go back to reference Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204(5):854–62 discussion 862-854.CrossRef Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204(5):854–62 discussion 862-854.CrossRef
24.
go back to reference Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149(5):680–8.CrossRef Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149(5):680–8.CrossRef
25.
go back to reference Ishizawa T, Hasegawa K, Kokudo N, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144(1):46–51.CrossRef Ishizawa T, Hasegawa K, Kokudo N, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144(1):46–51.CrossRef
26.
go back to reference Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRef
27.
go back to reference Asahina Y, Tsuchiya K, Tamaki N, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52(2):518–27.CrossRef Asahina Y, Tsuchiya K, Tamaki N, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52(2):518–27.CrossRef
28.
go back to reference Uwatoko S, Yamamoto K, Sasaki T, et al. Age is no longer a limit: two cases of hepatectomy in patients over 90 years old. Case Rep Gastroenterol. 2015;9(1):49–55.CrossRef Uwatoko S, Yamamoto K, Sasaki T, et al. Age is no longer a limit: two cases of hepatectomy in patients over 90 years old. Case Rep Gastroenterol. 2015;9(1):49–55.CrossRef
29.
go back to reference Okinaga H, Yasunaga H, Hasegawa K, Fushimi K, Kokudo N. Short-term outcomes following hepatectomy in elderly patients with hepatocellular carcinoma: an analysis of 10,805 septuagenarians and 2,381 Octo- and nonagenarians in Japan. Liver Cancer. 2018;7(1):55–64.CrossRef Okinaga H, Yasunaga H, Hasegawa K, Fushimi K, Kokudo N. Short-term outcomes following hepatectomy in elderly patients with hepatocellular carcinoma: an analysis of 10,805 septuagenarians and 2,381 Octo- and nonagenarians in Japan. Liver Cancer. 2018;7(1):55–64.CrossRef
30.
go back to reference Wu CC, Ho WM, Cheng SB, et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy. Ann Surg. 2006;243(2):173–80.CrossRef Wu CC, Ho WM, Cheng SB, et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy. Ann Surg. 2006;243(2):173–80.CrossRef
31.
go back to reference Portolani N, Baiocchi GL, Coniglio A, et al. Limited liver resection: a good indication for the treatment of hepatocellular carcinoma in elderly patients. Jpn J ClinOncol. 2011;41(12):1358–65.CrossRef Portolani N, Baiocchi GL, Coniglio A, et al. Limited liver resection: a good indication for the treatment of hepatocellular carcinoma in elderly patients. Jpn J ClinOncol. 2011;41(12):1358–65.CrossRef
32.
go back to reference Su CW, Lei HJ, Chau GY, et al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg. 2012;147(2):137–44.CrossRef Su CW, Lei HJ, Chau GY, et al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg. 2012;147(2):137–44.CrossRef
33.
go back to reference Yamada S, Shimada M, Miyake H, et al. Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma. Hepatol Res. 2012;42(5):454–8.CrossRef Yamada S, Shimada M, Miyake H, et al. Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma. Hepatol Res. 2012;42(5):454–8.CrossRef
34.
go back to reference Kim JM, Cho BI, Kwon CH, et al. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma. Am J Surg. 2015;209(2):391–7.CrossRef Kim JM, Cho BI, Kwon CH, et al. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma. Am J Surg. 2015;209(2):391–7.CrossRef
35.
go back to reference Wei F. Does an extreme age (≥80 years) affect outcomes in patients after liver cancer surgery? A meta-analysis. ANZ J Surg. 2018. [Epub ahead of print] Wei F. Does an extreme age (≥80 years) affect outcomes in patients after liver cancer surgery? A meta-analysis. ANZ J Surg. 2018. [Epub ahead of print]
36.
go back to reference Motoyama H, Kobayashi A, Yokoyama T, et al. Impact of advanced age on the short- and long-term outcomes in patients undergoing hepatectomy for hepatocellular carcinoma: a single-center analysis over a 20-year period. Am J Surg. 2015;209(4):733–41.CrossRef Motoyama H, Kobayashi A, Yokoyama T, et al. Impact of advanced age on the short- and long-term outcomes in patients undergoing hepatectomy for hepatocellular carcinoma: a single-center analysis over a 20-year period. Am J Surg. 2015;209(4):733–41.CrossRef
37.
go back to reference Kaibori M, Yoshii K. Hasegawa K, et al. Ann Surg: Treatment optimization for hepatocellular carcinoma in elderly patients in a Japanese Nationwide Cohort; 2018. Kaibori M, Yoshii K. Hasegawa K, et al. Ann Surg: Treatment optimization for hepatocellular carcinoma in elderly patients in a Japanese Nationwide Cohort; 2018.
38.
go back to reference Cucchetti A, Sposito C, Pinna AD, et al. Effect of age on survival in patients undergoing resection of hepatocellular carcinoma. Br J Surg. 2016;103(2):e93–9.CrossRef Cucchetti A, Sposito C, Pinna AD, et al. Effect of age on survival in patients undergoing resection of hepatocellular carcinoma. Br J Surg. 2016;103(2):e93–9.CrossRef
Metadata
Title
Liver resection for hepatocellular carcinoma in oldest old patients
Authors
Feng-Hsu Wu
Ching-Hui Shen
Shao-Ciao Luo
Jen-I Hwang
Wen-Shan Chao
Hong-Zen Yeh
Yee-Gee Jan
Yun Yen
Shao-Bin Cheng
Cheng-Chung Wu
Yi-Ling Lin
Fang-Ku P’eng
Publication date
01-12-2019
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1541-0

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue